-葡萄糖共载体2 (SGLT2) 的抑制和自身免疫
1Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.
Seminars in arthritis and rheumatism
|February 27, 2025
概括
-葡萄糖共运输体 (SGLT2) 抑制剂对慢性病 (CKD) 和自身免疫性疾病有好处. 需要进一步的研究来证实它们在患有活跃自身免疫性脏疾病的患者中的有效性和安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
背景情况:
- -葡萄糖共运输体 (SGLT2) 抑制剂已经改变了糖尿病,心力衰竭和慢性病 (CKD) 的管理.
- 患有自身免疫性疾病的患者面临心血管风险增加和CKD进展.
- 目前的试验排除了患有活跃自身免疫性脏疾病的患者,留下了治疗缺口.
研究的目的:
- 探索SGLT2抑制剂在患有自身免疫性疾病和CKD的患者中的潜在益处.
- 为了解决SGLT2抑制剂在活性自身免疫性脏疾病中的缺乏系统研究的问题.
主要方法:
- 对CKD和自身免疫性疾病中SGLT2抑制剂的现有文献的审查.
- 在主要SGLT2抑制剂试验 (DAPA-CKD,EMPA-KIDNEY) 中排除标准的分析.
主要成果:
- SGLT2 抑制剂显示出脏和心脏保护作用.
- 在体外和体内研究表明,SGLT2抑制剂可以控制SLE,狼性炎和类风湿性关节炎的自身免疫力.
- 试验中的排除标准限制了目前对SGLT2抑制剂在活性自身免疫性脏疾病中的使用的理解.
结论:
- SGLT2 抑制剂在治疗自身免疫性病方面表现有前途,因此需要对人类进行进一步的研究.
- 在遵守"病日规则"的情况下,SGLT2抑制剂的良好的安全概况支持它们的潜在使用.
- 关于SGLT2抑制剂在患有活性自身免疫性脏疾病的患者的疗效和安全性,存在重大知识差距.
相关概念视频
Glucose Transporters
22.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Glucose Absorption Into the Small Intestine
31.2K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.2K
Secondary Active Transport
117.3K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
117.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
151
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
151
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
142
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
142


